These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18600204)

  • 1. Overexpression of WNT2 and TSG101 genes in colorectal carcinoma.
    Ma XR; Edmund Sim UH; Pauline B; Patricia L; Rahman J
    Trop Biomed; 2008 Apr; 25(1):46-57. PubMed ID: 18600204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of tumor susceptibility gene TSG101 in human papillary thyroid carcinomas.
    Liu RT; Huang CC; You HL; Chou FF; Hu CC; Chao FP; Chen CM; Cheng JT
    Oncogene; 2002 Jul; 21(31):4830-7. PubMed ID: 12101421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the involvement of the Wnt 2 gene in human colorectal cancer.
    Vider BZ; Zimber A; Chastre E; Prevot S; Gespach C; Estlein D; Wolloch Y; Tronick SR; Gazit A; Yaniv A
    Oncogene; 1996 Jan; 12(1):153-8. PubMed ID: 8552386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tsg101 is upregulated in a subset of invasive human breast cancers and its targeted overexpression in transgenic mice reveals weak oncogenic properties for mammary cancer initiation.
    Oh KB; Stanton MJ; West WW; Todd GL; Wagner KU
    Oncogene; 2007 Aug; 26(40):5950-9. PubMed ID: 17369844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identical variant TSG101 transcripts in soft tissue sarcomas and various non-neoplastic tissues.
    Willeke F; Ridder R; Bork P; Klaes R; Mechtersheimer G; Schwarzbach M; Zimmer D; Kloor M; Lehnert T; Herfarth C; von Knebel Doeberitz M
    Mol Carcinog; 1998 Dec; 23(4):195-200. PubMed ID: 9869447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ITF-2 is disrupted via allelic loss of chromosome 18q21, and ITF-2B expression is lost at the adenoma-carcinoma transition.
    Herbst A; Bommer GT; Kriegl L; Jung A; Behrens A; Csanadi E; Gerhard M; Bolz C; Riesenberg R; Zimmermann W; Dietmaier W; Wolf I; Brabletz T; Göke B; Kolligs FT
    Gastroenterology; 2009 Aug; 137(2):639-48, 648.e1-9. PubMed ID: 19394332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Truncated TSG101 transcripts in human leukemia and lymphoma cell lines.
    Hosokawa Y; Nagai E; Seto M
    J Cancer Res Clin Oncol; 2000 Feb; 126(2):79-84. PubMed ID: 10664246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers.
    Zagani R; Hamzaoui N; Cacheux W; de Reyniès A; Terris B; Chaussade S; Romagnolo B; Perret C; Lamarque D
    Gastroenterology; 2009 Oct; 137(4):1358-66.e1-3. PubMed ID: 19549529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt2 complements Wnt/β-catenin signaling in colorectal cancer.
    Jung YS; Jun S; Lee SH; Sharma A; Park JI
    Oncotarget; 2015 Nov; 6(35):37257-68. PubMed ID: 26484565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TSG101 protein steady-state level is regulated posttranslationally by an evolutionarily conserved COOH-terminal sequence.
    Feng GH; Lih CJ; Cohen SN
    Cancer Res; 2000 Mar; 60(6):1736-41. PubMed ID: 10749147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 induction prevents accumulation of aberrant transcripts in cancer cells.
    Moyret-Lalle C; Duriez C; Van Kerckhove J; Gilbert C; Wang Q; Puisieux A
    Cancer Res; 2001 Jan; 61(2):486-8. PubMed ID: 11212237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the Wnt signalling pathway in colorectal tumorigenesis.
    Behrens J
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):672-5. PubMed ID: 16042571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stress-induced aberrant splicing of TSG101: association to high tumor grade and p53 status in breast cancers.
    Turpin E; Dalle B; de Roquancourt A; Plassa LF; Marty M; Janin A; Beuzard Y; de Thé H
    Oncogene; 1999 Dec; 18(54):7834-7. PubMed ID: 10618725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perturbation of TSG101 protein affects cell cycle progression.
    Zhong Q; Chen Y; Jones D; Lee WH
    Cancer Res; 1998 Jul; 58(13):2699-702. PubMed ID: 9661875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes.
    Pendás-Franco N; Aguilera O; Pereira F; González-Sancho JM; Muñoz A
    Anticancer Res; 2008; 28(5A):2613-23. PubMed ID: 19035286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Wnt pathway components frizzled and disheveled in colon cancer arising in patients with inflammatory bowel disease.
    You XJ; Bryant PJ; Jurnak F; Holcombe RF
    Oncol Rep; 2007 Sep; 18(3):691-4. PubMed ID: 17671721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of rearrangements in the tumour susceptibility gene TSG101 in human breast cancer.
    Steiner P; Barnes DM; Harris WH; Weinberg RA
    Nat Genet; 1997 Aug; 16(4):332-3. PubMed ID: 9241265
    [No Abstract]   [Full Text] [Related]  

  • 19. [TSG101 and breast cancer: a correctly named tumor-suppressor gene?].
    Bénard J; Ahomadégbé JC
    Bull Cancer; 1997 Dec; 84(12):1141-2. PubMed ID: 9587367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
    Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
    J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.